Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 09, 2024 06:00 ET | Source: Arbor Biotechnologies Inc

Arbor Biotechnologies Presents Data Supporting Clinical Development of ABO-101 and Robust Potential of Platform to Enable Therapeutic Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

Presented data which, along with ongoing IND-enabling studies, demonstrate efficacy and pharmacology of ABO-101 in non-human primates (NHPs), supporting continued development as a potential novel gene...
May 08, 2024 07:00 ET | Source: Arbor Biotechnologies Inc

Arbor Biotechnologies Announces Acquisition of Serendipity

CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, today announced the...
April 22, 2024 17:09 ET | Source: Arbor Biotechnologies Inc

Arbor Biotechnologies to Present Data Supporting Therapeutic Programs in PH1 and ALS, and the Discovery of a Novel Type V Nuclease at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

- Oral and poster presentations showcase data demonstrating pipeline progress and continued advancement of Arbor’s pipeline programs toward the clinic - Oral presentation with data validating...
January 03, 2024 08:01 ET | Source: Arbor Biotechnologies Inc

4DMT and Arbor Biotechnologies Establish Partnership to Co-Develop and Co-Commercialize Next-Generation Genetic Medicines for CNS Diseases

Partnership brings together two leaders in next-generation genetic medicines to engineer, co-develop and co-commercialize (50:50 profit share) AAV-delivered CRISPR/Cas-based therapeutics for up to six...
November 07, 2023 07:00 ET | Source: Arbor Biotechnologies Inc

Arbor Biotechnologies Appoints Industry Veteran R. Nolan Townsend to Board of Directors

CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the...
August 29, 2023 07:00 ET | Source: Arbor Biotechnologies Inc

Arbor Biotechnologies Appoints Ajim Tamboli as Chief Financial Officer

CAMBRIDGE, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the...
August 07, 2023 07:00 ET | Source: Arbor Biotechnologies Inc

Arbor Biotechnologies Appoints Deanna M. Petersen as Chief Business Officer

CAMBRIDGE, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the...
May 23, 2023 07:00 ET | Source: Arbor Biotechnologies Inc

Arbor Biotechnologies to Present at the Stifel 2023 Tailoring Genes: Genetic Medicines Day

CAMBRIDGE, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced Devyn Smith,...
May 02, 2023 16:30 ET | Source: Arbor Biotechnologies Inc

Arbor Biotechnologies Announces Presentations at the 2023 Annual Meeting of the American Society of Gene & Cell Therapy

CAMBRIDGE, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that three...
April 12, 2023 07:00 ET | Source: Arbor Biotechnologies Inc

Arbor Biotechnologies Appoints Dr. Daniel Ory as Chief Medical Officer

CAMBRIDGE, Mass., April 12, 2023 (GLOBE NEWSWIRE) -- Arbor Biotechnologies®, a biotechnology company discovering and developing the next generation of genetic editing medicines, today announced the...